In this podcast, Dr Heidi Moawad interviews a neurologist currently researching new, available treatments in headache medicine. from Front page feed http://bit.ly/2HVwnPv
Mislocalization of the TDP-43 protein alters the genetic instructions for UNC13A. The findings provide a potential new therapeutic target for the treatment of ALS and frontotemporal dementia.
Comments
Post a Comment